| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = $158,357 ) |
| | 2020 | 2020 | NIAID | 6700 B ROCKLEDGE DRIVE | BETHESDA | MD | 20817-1824 | MONTGOMERY | USA | K22AI136593 | Innate Lymphoid Cell Loss in HIV-1 and SIV Infection | 000 | 1 | NIH | 3/11/2020 | $158,357 |
|
| Issue Date FY: 2018 ( Subtotal = -$20 ) |
| | 2018 | 2016 | NIAID | 6700 B ROCKLEDGE DRIVE | BETHESDA | MD | 20817-1824 | MONTGOMERY | USA | K22AI108719 | Regulation of commensal-specific T cells during gastrointestinal inflammation | 000 | 2 | NIH | 11/21/2017 | -$20 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | NIAID | 6700 B ROCKLEDGE DRIVE | BETHESDA | MD | 20817-1824 | MONTGOMERY | USA | K22AI112570 | Super-enhancer structure defines a signature of inflammatory bowel disease (IBD) | 000 | 2 | NIH | 8/4/2017 | $0 |
|
|
